These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12124517)

  • 1. [Mycobacterial bovis BCG cutaneous infections following mesotherapy: 2 cases].
    Marco-Bonnet J; Beylot-Barry M; Texier-Maugein J; Barucq JP; Supply P; Doutre MS; Beylot C
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):728-31. PubMed ID: 12124517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [BCG-induced mycobacterium infection induced by alternative medicine].
    Paul C; Burguiere AM; Vincent V; Susbielle P; Bonvalet D; Dubertret L
    Ann Dermatol Venereol; 1997; 124(10):710-2. PubMed ID: 9740870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous tuberculosis after mesotherapy: report of six cases.
    Orjuela D; Puerto G; Mejía G; Castro C; Garzón MC; García LM; Hernández E; Ribón W; Rodríguez G
    Biomedica; 2010; 30(3):321-6. PubMed ID: 21713332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disfiguring scarring following mesotherapy-associated Mycobacterium cosmeticum infection.
    Beer K; Waibel J
    J Drugs Dermatol; 2009 Apr; 8(4):391-3. PubMed ID: 19363858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Soft-tissue infections due to non-tuberculous mycobacteria following mesotherapy. What is the price of beauty].
    Rivera-Olivero IA; Guevara A; Escalona A; Oliver M; Pérez-Alfonzo R; Piquero J; Zerpa O; de Waard JH
    Enferm Infecc Microbiol Clin; 2006 May; 24(5):302-6. PubMed ID: 16762255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of PCR assays for rapid diagnosis of BCG infection in children.
    Su WJ; Huang CY; Huang CY; Perng RP
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):380-4. PubMed ID: 11334259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberculosis following mycobacteriosis. Apropos of 2 cases].
    Kubín M; Horák Z; Poláková H
    Rev Mal Respir; 1984; 1(3):157-60. PubMed ID: 6382476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontuberculous mycobacteria infection after mesotherapy: preliminary report of 15 cases.
    Sañudo A; Vallejo F; Sierra M; Hoyos JG; Yepes S; Wolff JC; Correa LA; Montealegre C; Navarro P; Bedoya E; Sanclemente G
    Int J Dermatol; 2007 Jun; 46(6):649-53. PubMed ID: 17550571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy.
    Regnier S; Cambau E; Meningaud JP; Guihot A; Deforges L; Carbonne A; Bricaire F; Caumes E
    Clin Infect Dis; 2009 Nov; 49(9):1358-64. PubMed ID: 19814609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesotherapy and cutaneous Mycobacterium fortuitum infection.
    Difonzo EM; Campanile GL; Vanzi L; Lotti L
    Int J Dermatol; 2009 Jun; 48(6):645-7. PubMed ID: 19538379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal abscess due to disseminated Bacille Calmette-Guérin infection.
    Alborzi A; Mostafavi N
    Jpn J Infect Dis; 2007 Nov; 60(6):392-3. PubMed ID: 18032842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium marinum infections in transplant recipients: case report and review of the literature.
    Pandian TK; Deziel PJ; Otley CC; Eid AJ; Razonable RR
    Transpl Infect Dis; 2008 Oct; 10(5):358-63. PubMed ID: 18482202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated cutaneous BCG infection following BCG immunotherapy in patients with lepromatous leprosy.
    Khullar G; Narang T; Sharma K; Saikia UN; Dogra S
    Lepr Rev; 2015 Jun; 86(2):180-5. PubMed ID: 26502690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculous subcutaneous abscesses developing during chemotherapy for pulmonary tuberculosis.
    Chen CH; Tsai JJ; Shih JF; Perng RP
    Scand J Infect Dis; 1993; 25(1):149-52. PubMed ID: 8460341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term course and treatment of a cutaneous BCG infection.
    Mise K; Goic-Barisic I; Bradaric A; Tonkic M; Vrsalovic N; Karanovic J
    J Dermatolog Treat; 2008; 19(6):333-6. PubMed ID: 18608726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pneumoconiosis and mycobacterial infection].
    Kekkaku; 2003 Nov; 78(11):711-5. PubMed ID: 14672049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.